Pipeline

Pipeline

Cytovation’s product pipeline offers potentially new treatments for multiple cancers where no satisfactory options currently exist.

Targeted Immunotherapy for Cancer

CyPep-01 selectively targets and lyses tumour cells and induces a long-lasting tumour-specific immune response while leaving healthy cells intact.

CyPep-O1 is a novel proprietary peptide currently in pre-clinical development as a potential new treatment for multiple cancers.